Evidence map›Paper›PMID 39644424›Full record

ArticleEndocrine2025

Regional brain glucose uptake following gastric bypass surgery during normo- and hypoglycemic clamp: a pilot FDG-PET study.

Giovanni Fanni, Sofia Kvernby, Sadiq Radhi, Argyri Mathioudaki, Magnus Sundbom, Sven Haller, Erika Roman, Johan Wikström, Mark Lubberink, Jan W Eriksson

Abstract read
In one paragraph

Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni FanniDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7920-8909
Sofia KvernbyDepartment of Surgical Sciences, Molecular Imaging and Medical Physics, Uppsala University, Uppsala, Sweden.
Sadiq RadhiDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Argyri MathioudakiDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
Magnus SundbomDepartment of Surgical Sciences, Surgery, Uppsala University, Uppsala, Sweden.
Sven HallerDepartment of Surgical Sciences, Neuroradiology, Uppsala University, Uppsala, Sweden.
Erika RomanDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Johan WikströmDepartment of Surgical Sciences, Neuroradiology, Uppsala University, Uppsala, Sweden.
Mark LubberinkDepartment of Surgical Sciences, Molecular Imaging and Medical Physics, Uppsala University, Uppsala, Sweden.
Jan W ErikssonDepartment of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden. jan.eriksson@medsci.uu.se.

Funding

European Commission via the Marie Sklodowska Curie Innovative Training Network TREATMENT H2020-MSCA-ITN-721236Novo Nordisk NNF23OC0084483Novo Nordisk Fonden NNF20OC0063864Svenska Diabetesstiftelsen DIA2019-490Svenska Diabetesstiftelsen,Sweden DIA 2021-661
6 · The paper itself

Abstract

purposeWe aimed to characterize the RYGB-induced changes in the dynamics of brain glucose uptake. We addressed heterogeneity between brain regions during experimental normo- and hypoglycemia and explored associations with anthropometric and metabolic outcomes of RYGB.

methodsAnalyses of regional brain glucose uptake were performed on 9 individuals with obesity and no diabetes, investigated with combined brain

resultsFDG uptake rate during hypoglycemia was higher than during normoglycemia in all brain regions, both before and after RYGB. Moreover, in most regions and especially in cortical areas involved in inhibitory behavioral control, FDG uptake rate tended to be reduced after surgery during normoglycemia but elevated during hypoglycemia. However, these post-surgical changes in FDG uptake rate were opposite in the hypothalamus. Thus, the hypo-to-normoglycemia FDG clearance ratio tended to increase in all brain regions following RYGB, but not in the amygdala and the hypothalamus. Changes in regional FDG uptake rate after RYGB during normoglycemia were associated with weight loss and improved systemic insulin sensitivity.

conclusionUsing dynamic FDG-PET, we show region-specific patterns of changes in glucose utilization following RYGB. In the hypothalamus, glucose uptake during normoglycemia tended to rise after RYGB while it was reduced in cortical regions involved in behavioral control. Following RYGB, the hypothalamus and amygdala, in contrast to other regions, displayed trends of reduced glucose uptake during hypoglycemia. These pilot results highlight the brain effects of RYGB and suggest behavioral and neuroendocrine adaptations which contribute to its antidiabetic effects.

Indexed as

BrainGastric BypassGlucoseHypoglycemiaObesityAdultBlood GlucoseFemaleFluorodeoxyglucose F18Glucose Clamp TechniqueHumansMagnetic Resonance ImagingMaleMiddle AgedPilot ProjectsPositron-Emission TomographyBlood GlucoseFluorodeoxyglucose F18GlucoseBrain metabolismCounterregulatory response.FDG-PETRYGB

Identifiers

PMID39644424
PMCPMC11933149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.